SS-31, known scientifically as elamipretide (and historically as MTP-131 or Bendavia), is a synthetic, mitochondria-targeted tetrapeptide developed from the Szeto-Schiller peptide series. Its defining feature is an alternating aromatic-cationic structure that drives it selectively into the inner mitochondrial membrane, where it associates with the phospholipid cardiolipin. This positions SS-31 as one of the most studied tools in mitochondrial bioenergetics research. Bergdorf Bioscience supplies SS-31 (Elamipretide) at 10 mg per vial as a high-purity reference compound for laboratory and research use only.
Scientific Foundation and Study Background
Elamipretide emerged from work on aromatic-cationic peptides at Weill Cornell Medicine and has since accumulated an unusually deep clinical research record for a peptide, spanning Barth syndrome, primary mitochondrial myopathy, geographic atrophy in dry age-related macular degeneration, and heart failure. While several late-stage trials did not meet their primary endpoints, mechanistic and secondary findings have repeatedly pointed to genuine effects on mitochondrial structure and function.
- TAZPOWER (Barth syndrome): the randomized phase did not meet its primary endpoint, but the open-label extension showed improved knee-extensor muscle strength (and some cardiac measures) over extended follow-up, which supported elamipretide's 2025 FDA accelerated approval for Barth syndrome.
- MMPOWER-3 (primary mitochondrial myopathy): the primary six-minute-walk endpoint was not met, though reduced fatigue was reported in participants with specific mitochondrial DNA defects.
- ReCLAIM (dry AMD) and PROGRESS-HF (heart failure): primary endpoints were not achieved, but slowed ellipsoid-zone degradation and improved markers of mitochondrial function and quality of life were observed.
Biochemical Properties and Stability
SS-31 is a four-residue peptide built around the non-natural amino acid 2',6'-dimethyltyrosine (Dmt) and a D-arginine residue, which together give the molecule its characteristic aromatic-cationic motif and metabolic stability. The compound is highly water-soluble and is cleared rapidly, substantially by renal excretion, giving it a short systemic half-life. Lyophilized material should be stored cold and protected from light; reconstituted solutions are best kept refrigerated and used promptly.
- Sequence: H-D-Arg-Dmt-Lys-Phe-NH2 (D-Arg-2',6'-dimethyl-L-Tyr-L-Lys-L-Phe-amide)
- Molecular formula: C32H49N9O5
- Molar mass: about 639.8 g/mol
- CAS number: 736992-21-5 (free base); acetate salt 1334953-95-5
- PubChem CID: 11764719
- Systemic half-life: approximately 4 hours (roughly 2 to 4 hour range across species and route), with rapid, substantially renal clearance
- Molecular target: cardiolipin in the inner mitochondrial membrane (no classical cell-surface receptor)
Buy SS-31 (Elamipretide) at Bergdorf Bioscience
Each vial contains 10 mg of SS-31 (Elamipretide), manufactured to a verified purity of at least 99% and accompanied by third-party HPLC and mass-spectrometry documentation. Every batch is independently tested so that researchers receive material of consistent, reference-grade quality.
- >=99% purity confirmed by HPLC and mass spectrometry
- Certificate of Analysis (COA) available for every batch
- Supplied as a lyophilized powder, 10 mg per vial, for reconstitution in the laboratory
- Research protocol context only: elamipretide has been administered at about 40 mg subcutaneously once daily in clinical research; this is reference information, not dosing guidance (research context)
- Strictly for in vitro and laboratory research use; not for human or veterinary consumption
As a mitochondria-targeted compound, SS-31 is frequently studied alongside other cellular-energy and longevity research peptides such as MOTS-c and NAD+, making it a cornerstone of bioenergetics and aging research programs.
Worldwide Shipping
Bergdorf Bioscience ships SS-31 (Elamipretide) worldwide with discreet, temperature-conscious packaging and tracked delivery. Orders are processed promptly so that research-grade material reaches your laboratory in reliable condition.
Mitochondria-targeted tetrapeptide that binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae, preserving membrane potential and boosting ATP synthesis while reducing reactive oxygen species.
Merk: Doseringene som er oppgitt, tilsvarer typiske intervaller fra publisert forskningslitteratur. De erstatter ikke råd fra en kvalifisert forsker eller lege.
Hvert parti analyseres av et uavhengig laboratorium via HPLC før forsendelse. Vi dokumenterer renhet (gj.sn. 99,43 % i 2026), massespectrometrisk identitet og sterilitet. Produksjonen følger GMP-standarder ved ISO-sertifiserte laboratorier.